Compounded semaglutide and tirzepatide from licensed 503A pharmacies typically range $149/mo monthly, depending on dose and frequency, with no middleman markup
Cyanocobalamin dosing is prescriber-specified
GLP-1 drugs stimulate the release of insulin when blood sugar is elevated, inhibit the release of glucagon (a hormone that raises glucose), and slow stomach emptying, helping people feel fuller for longer
Dietary changes are often overlooked but highly effective
The program theoretically will expire at the end of 2027, although those taking GLP-1 drugs for obesity at that point are likely to advocate for its continuation
Glucagon-like Peptide 1(GLP-1): an intestinal hormone signalling nutritional abundance, with an unusual therapeutic potential